Cargando…

Improved Characteristics of RANKL Immuno-PET Imaging Using Radiolabeled Antibody Fab Fragments

Purpose: RANKL expression in the tumor microenvironment has been identified as a biomarker of immune suppression, negating the effect of some cancer immunotherapies. Previously we had developed a radiotracer based on the FDA-approved RANKL-specific antibody denosumab, [(89)Zr]Zr-DFO-denosumab, enabl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dewulf, Jonatan, Hrynchak, Ivanna, Geudens, Sarah, Pintelon, Isabel, Vangestel, Christel, Sereno, José, van Dam, Peter A., Abrunhosa, Antero J., Elvas, Filipe, Van den Wyngaert, Tim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147590/ https://www.ncbi.nlm.nih.gov/pubmed/35631525 http://dx.doi.org/10.3390/pharmaceutics14050939

Ejemplares similares

Immuno-PET Molecular Imaging of RANKL in Cancer
por: Dewulf, Jonatan, et al.
Publicado: (2021)

Development of Antibody Immuno-PET/SPECT Radiopharmaceuticals for Imaging of Oncological Disorders—An Update
por: Dewulf, Jonatan, et al.
Publicado: (2020)

Nanobody-Based Theranostic Agents for HER2-Positive Breast Cancer: Radiolabeling Strategies
por: Hrynchak, Ivanna, et al.
Publicado: (2021)

Antibody and Nanobody Radiolabeling with Copper-64: Solid vs. Liquid Target Approach
por: Hrynchak, Ivanna, et al.
Publicado: (2023)

Site-specific (68)Ga-labeled nanobody for PET imaging of CD70 expression in preclinical tumor models
por: Dewulf, Jonatan, et al.
Publicado: (2023)

Characterization of Structurally Diverse (18)F-Labeled d-TCO Derivatives as a PET Probe for Bioorthogonal Pretargeted Imaging
por: Adhikari, Karuna, et al.
Publicado: (2023)

Site-Specific (68)Ga Radiolabeling of Trastuzumab Fab via Methionine for ImmunoPET Imaging
por: Yue, Thomas T. C., et al.
Publicado: (2023)

Fully Automated Production of [(68)Ga]GaFAPI-46 with Gallium-68 from Cyclotron Using Liquid Targets
por: Fonseca, Alexandra I., et al.
Publicado: (2023)

Molecular imaging of hypoxia with radiolabelled agents
por: Mees, Gilles, et al.
Publicado: (2009)

In Vivo Tracking of Extracellular Vesicles by Nuclear Imaging: Advances in Radiolabeling Strategies
por: Almeida, Sara, et al.
Publicado: (2020)

RANK-RANKL Signaling in Cancer of the Uterine Cervix: A Review
por: van Dam, Peter A., et al.
Publicado: (2019)

Advances in the automated synthesis of 6-[(18)F]Fluoro-L-DOPA
por: Neves, Ângela C. B., et al.
Publicado: (2021)

Correction to: Advances in the automated synthesis of 6-[(18)F]Fluoro-L-DOPA
por: Neves, Ângela C. B., et al.
Publicado: (2021)

Production of GMP-Compliant Clinical Amounts of Copper-61 Radiopharmaceuticals from Liquid Targets
por: Fonseca, Alexandra I., et al.
Publicado: (2022)

First-in-human study of a novel cell death tracer [(99m)Tc]Tc-Duramycin: safety, biodistribution and radiation dosimetry in healthy volunteers
por: Metelerkamp Cappenberg, Taco, et al.
Publicado: (2023)

Antibody Fragment and Affibody ImmunoPET Imaging Agents: Radiolabelling Strategies and Applications
por: Fu, Ruisi, et al.
Publicado: (2018)

Single chain Fab (scFab) fragment
por: Hust, Michael, et al.
Publicado: (2007)

Radionuclide Imaging of Cytotoxic Immune Cell Responses to Anti-Cancer Immunotherapy
por: Lauwerys, Louis, et al.
Publicado: (2022)

High-Affinity Recombinant Antibody Fragments (Fabs) Can Be Applied in Peptide Enrichment Immuno-MRM Assays
por: Whiteaker, Jeffrey R., et al.
Publicado: (2014)

State of the Art in Radiolabeling of Antibodies with Common and Uncommon Radiometals for Preclinical and Clinical Immuno-PET
por: Chomet, Marion, et al.
Publicado: (2021)

How to Modulate Tumor Hypoxia for Preclinical In Vivo Imaging Research
por: De Bruycker, Sven, et al.
Publicado: (2018)

PET imaging with radiolabeled antibodies and tyrosine kinase inhibitors: immuno-PET and TKI-PET
por: van Dongen, Guus A. M. S., et al.
Publicado: (2012)

Characterization of [(99m)Tc]Duramycin as a SPECT Imaging Agent for Early Assessment of Tumor Apoptosis
por: Elvas, Filipe, et al.
Publicado: (2015)

Enhanced Tumor Localization of Radiolabeled Fab Fragments of Monoclonal Antibody A7 in Nude Mice Bearing Human Pancreatic Carcinoma Xenografts
por: Otsuji, Eigo, et al.
Publicado: (1993)

Molecular Imaging of Apoptosis: The Case of Caspase-3 Radiotracers
por: Beroske, Lucas, et al.
Publicado: (2021)

Preclinical Evaluation of a Novel (18)F-Labeled dTCO-Amide Derivative for Bioorthogonal Pretargeted Positron Emission Tomography Imaging
por: Ruivo, Eduardo, et al.
Publicado: (2020)

Production of single chain Fab (scFab) fragments in Bacillus megaterium
por: Jordan, Eva, et al.
Publicado: (2007)

Matching the Decay Half-Life with the Biological Half-Life: ImmunoPET Imaging with (44)Sc-Labeled Cetuximab Fab Fragment
por: Chakravarty, Rubel, et al.
Publicado: (2014)

Development of [(89)Zr]Zr-hCD103.Fab01A and [(68)Ga]Ga-hCD103.Fab01A for PET imaging to noninvasively assess cancer reactive T cell infiltration: Fab-based CD103 immunoPET
por: Fan, Xiaoyu, et al.
Publicado: (2023)

Automated light-induced synthesis of (89)Zr-radiolabeled antibodies for immuno-positron emission tomography
por: Klingler, Simon, et al.
Publicado: (2022)

Translational immunoPET imaging using a radiolabeled GD2-specific antibody in neuroblastoma
por: Schmitt, Julia, et al.
Publicado: (2022)

DutaFabs are engineered therapeutic Fab fragments that can bind two targets simultaneously
por: Beckmann, Roland, et al.
Publicado: (2021)

Early Changes in [(18)F]FDG Uptake as a Readout for PI3K/Akt/mTOR Targeted Drugs in HER-2-Positive Cancer Xenografts
por: Dockx, Yanina, et al.
Publicado: (2021)

p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging
por: Perk, Lars R., et al.
Publicado: (2009)

Production of Antibody Fab Fragments in Escherichia coli
por: Tachibana, Hiroshi, et al.
Publicado: (2011)

Bicistronic DNA display for in vitro selection of Fab fragments
por: Sumida, Takeshi, et al.
Publicado: (2009)

Radiolabeled Bombesin Analogs
por: Mansi, Rosalba, et al.
Publicado: (2021)

Fragments of the Fab-3 and Fab-4 Boundaries of the Drosophila melanogaster Bithorax Complex That Include CTCF Sites Are not Effective Insulators
por: Kyrchanova, O. V., et al.
Publicado: (2022)

Engineering the Fab fragment of the anti-IgE omalizumab to prevent Fab crystallization and permit IgE-Fc complex crystallization
por: Mitropoulou, Alkistis N., et al.
Publicado: (2020)

Radiolabeled novel mAb 4G1 for immunoSPECT imaging of EGFRvIII expression in preclinical glioblastoma xenografts
por: Liu, Xujie, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_b6art0bi79t6otls1j16r72e62